Get startedLog in
    Picture of Theradiag SA logo

    ALTER — Theradiag SA Income Statement

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapFalling Star
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Theradiag SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    R2018
    December 31st
    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    FAS
    FAS
    FAS
    FAS
    FAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue8.919.6410.411.112.2
    Cost of Revenue
    Gross Profit7.217.38.088.269.58
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses9.819.5911.112.112.8
    Operating Profit-0.90.052-0.647-0.967-0.609
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-1.060.067-0.615-1.03-0.693
    Provision for Income Taxes
    Net Income After Taxes-0.7860.349-0.231-0.767-0.488
    Net Income Before Extraordinary Items
    Net Income-0.7860.349-0.231-0.767-0.488
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-0.7860.349-0.231-0.767-0.488
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.071-0.009-0.021-0.054-0.021
    Dividends per Share